GET THE APP

The Impact of Renal Function on Coronary Bypass Surgery: Assessment and Management
..

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

Short Communication - (2023) Volume 13, Issue 3

The Impact of Renal Function on Coronary Bypass Surgery: Assessment and Management

Peter Morgan*
*Correspondence: Peter Morgan, Department of Medicine, Yale University, New Haven, Connecticut, USA, Email:
Department of Medicine, Yale University, New Haven, Connecticut, USA

Received: 21-Feb-2023, Manuscript No. JNT-23-95502; Editor assigned: 23-Feb-2023, Pre QC No. P-95502; Reviewed: 07-Mar-2023, QC No. Q-95502; Revised: 13-Mar-2023, Manuscript No. R-95502; Published: 20-Mar-2023 , DOI: 10.37421/2161-0959.2023.13.444
Citation: Morgan, Peter. “The Impact of Renal Function on Coronary Bypass Surgery: Assessment and Management." J Nephrol Ther 13 (2023): 444.
Copyright: © 2023 Morgan P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Coronary artery disease is a leading cause of mortality worldwide. Coronary artery bypass surgery is a common procedure used to treat patients with severe coronary artery disease. However, it is associated with the risk of renal dysfunction and acute kidney injury. Renal dysfunction can increase morbidity and mortality, length of hospital stay, and healthcare costs. Therefore, it is crucial to understand the relationship between renal function and coronary bypass surgery to improve patient outcomes.

Renal function

The renal system, also known as the urinary system, is responsible for filtering and eliminating waste products from the body, regulating electrolyte and acid-base balance, and maintaining fluid homeostasis. The kidneys are the primary organs of the renal system and are responsible for carrying out these functions. Renal function refers to the ability of the kidneys to carry out their functions effectively. This is measured through various tests that evaluate kidney function, such as blood and urine tests, imaging studies, and biopsy. The most commonly used tests for evaluating renal function are serum creatinine and blood urea nitrogen (BUN) levels.

Serum creatinine is a waste product produced by muscle metabolism that is eliminated by the kidneys. When renal function declines, serum creatinine levels increase, indicating impaired kidney function. BUN is another waste product produced by the liver that is eliminated by the kidneys. Elevated BUN levels also indicate impaired renal function. The glomerular filtration rate (GFR) is another measure of renal function that reflects the rate at which blood is filtered by the kidneys. The GFR is calculated using serum creatinine levels, age, sex, and race. A GFR less than 60 mL/min/1.73 m2 for three months or longer is a sign of chronic kidney disease (CKD).

CKD is a common condition that affects millions of people worldwide. It is often asymptomatic in the early stages but can progress to end-stage renal disease (ESRD) if left untreated. ESRD requires kidney replacement therapy, such as dialysis or kidney transplantation. Maintaining renal function is essential for overall health and well-being. There are several lifestyle modifications that can help improve renal function, such as maintaining a healthy weight, avoiding tobacco and excessive alcohol consumption, managing blood pressure and blood sugar levels, and staying hydrated. Regular exercise and a healthy diet that is low in sodium and high in fruits and vegetables can also help support renal function..

Description

Coronary bypass surgery

Coronary bypass surgery, also known as coronary artery bypass grafting (CABG), is a surgical procedure that is commonly performed on the heart. However, in rare cases, a similar procedure may be performed on the kidneys to improve blood flow and function. This procedure is called renal artery bypass surgery.

The renal arteries are responsible for supplying blood to the kidneys. When these arteries become narrowed or blocked due to a buildup of plaque, the kidneys may not receive adequate blood flow. This can lead to kidney damage or failure. In some cases, renal artery stenosis can be treated with medication or angioplasty, but in severe cases, renal artery bypass surgery may be necessary [1].

During renal artery bypass surgery, a blood vessel from another part of the body, such as the leg, is used to create a detour around the blocked renal artery. This new blood vessel, known as a graft, is attached to the aorta, a large blood vessel that carries oxygen-rich blood from the heart to the rest of the body. The other end of the graft is attached to the renal artery, beyond the blockage.

The surgery is typically performed under general anesthesia, and the patient will be closely monitored during and after the procedure. Recovery time will depend on the individual and the extent of the surgery. Patients may experience some pain or discomfort, and will need to avoid strenuous activity for several weeks.

While renal artery bypass surgery can be an effective treatment for renal artery stenosis, it does carry some risks. These include bleeding, infection, blood clots, and damage to other organs or blood vessels during the surgery. In addition, the graft may become blocked or narrowed over time, which could require further treatment.

It is important to note that renal artery bypass surgery is a rare procedure and is usually only recommended when other treatment options have been exhausted. In many cases, kidney function can be improved with medication, lifestyle changes, or minimally invasive procedures such as angioplasty.

Renal function and coronary bypass surgery

The impact of coronary bypass surgery on renal function depends on various factors, including preoperative renal function, type of surgery, and length of surgery. Patients with pre-existing renal dysfunction are more likely to develop AKI during coronary bypass surgery. On-pump coronary bypass surgery is associated with a higher risk of AKI than off-pump coronary bypass surgery. Prolonged surgery time can also increase the risk of AKI [2,3].

Management of renal dysfunction during coronary bypass surgery

During coronary bypass surgery, there is a risk of renal dysfunction due to several factors such as the use of contrast agents during imaging studies, exposure to cardiopulmonary bypass, and the use of nephrotoxic medications. The management of renal dysfunction during coronary bypass surgery involves several strategies to minimize the risk of renal injury and to optimize renal function during and after the procedure.

One of the key strategies to manage renal dysfunction during coronary bypass surgery is to minimize the use of nephrotoxic medications. This includes avoiding or minimizing the use of non-steroidal anti-inflammatory drugs (NSAIDs) and other medications that can affect renal function. Instead, alternative pain management strategies such as opioids may be used.

Another strategy is to optimize hemodynamic parameters during the procedure. This includes maintaining adequate blood pressure and perfusion to the kidneys, as well as optimizing oxygen delivery to the tissues. This can be achieved through careful monitoring of hemodynamic parameters and adjusting medications or fluids as needed.

The use of cardiopulmonary bypass during coronary bypass surgery can also increase the risk of renal dysfunction. To minimize this risk, techniques such as minimizing the duration of cardiopulmonary bypass, using lowpotassium cardioplegia solutions, and optimizing fluid management may be used. Additionally, the use of regional perfusion techniques may be considered in high-risk patients [4].

Hydration is another important aspect of managing renal dysfunction during coronary bypass surgery. Adequate hydration can help prevent acute kidney injury (AKI) by promoting renal blood flow and minimizing the concentration of nephrotoxic substances in the urine. However, overhydration should be avoided as it can lead to fluid overload and exacerbate cardiac and renal dysfunction.

In addition to these strategies, preoperative screening and identification of patients at high risk for renal dysfunction can help guide management and treatment during and after the procedure. Patients with pre-existing renal dysfunction or comorbidities such as diabetes or hypertension may require more aggressive management to prevent AKI.

Postoperative management of renal dysfunction during coronary bypass surgery involves careful monitoring of renal function and adjusting management strategies as needed. This includes monitoring serum creatinine levels and urine output, as well as optimizing fluid and electrolyte balance. In some cases, renal replacement therapy such as dialysis may be necessary to manage AKI.

Clinical studies and evidence

Clinical studies and evidence are important in guiding the management of renal dysfunction during coronary bypass surgery. Several clinical studies have been conducted to evaluate the effectiveness of various management strategies and to identify risk factors for renal dysfunction during the procedure.

One study published in the Journal of Thoracic and Cardiovascular Surgery evaluated the effectiveness of prophylactic hemofiltration in preventing AKI during coronary bypass surgery. The study found that prophylactic hemofiltration was effective in reducing the incidence of AKI in high-risk patients undergoing the procedure. Another study published in the Journal of the American Society of Nephrology evaluated the effectiveness of remote ischemic preconditioning (RIPC) in reducing the risk of AKI during coronary bypass surgery. The study found that RIPC was effective in reducing the incidence of AKI in patients undergoing the procedure.

In addition to these studies, several guidelines and recommendations have been developed to guide the management of renal dysfunction during coronary bypass surgery [5]. The American College of Cardiology and American Heart Association recommend the use of iodinated contrast agents with caution in patients with pre-existing renal dysfunction, as well as careful hydration and monitoring of renal function during and after the procedure.

The European Society of Cardiology recommends the use of prophylactic hemofiltration or hemodialysis in high-risk patients undergoing coronary bypass surgery. The guidelines also recommend the use of RIPC and minimizing the use of cardiopulmonary bypass to reduce the risk of AKI.

Overall, the evidence suggests that a multidisciplinary approach involving the cardiac and renal teams can help optimize outcomes for patients undergoing coronary bypass surgery. This approach should involve careful preoperative screening and identification of high-risk patients, as well as the use of evidence-based management strategies to minimize the risk of renal dysfunction during and after the procedure.

Conclusion

Renal dysfunction is a common complication of coronary bypass surgery. Understanding the relationship between renal function and coronary bypass surgery is crucial for improving patient outcomes.

Acknowledgement

Not applicable.

Conflict of Interest

There is no conflict of interest by authors.

References

  1. Kohli, Harbir S., Madhu C. Bhaskaran, Thangamani Muthukumar and Kandavel Thennarasu, et al. "Treatment-related acute renal failure in the elderly: a hospital-based prospective study." Nephrol Dial Transplant 15 (2000): 212-217.
  2. Google Scholar, Crossref, Indexed at

  3. Waechter, Jason, Anand Kumar, Stephen E. Lapinsky and John Marshall, et al. "Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study." Crit Care Med 42 (2014): 2158-2168.
  4. Google Scholar, Crossref, Indexed at

  5. Raghunathan, Karthik, Anthony Bonavia, Brian H. Nathanson and Christopher A. Beadles, et al. "Association between initial fluid choice and subsequent in-hospital mortality during the resuscitation of adults with septic shock." Anesthesiol 123 (2015): 1385-1393.
  6. Google Scholar, Crossref, Indexed at

  7. Gordon, Anthony C., Alexina J. Mason, Neeraja Thirunavukkarasu and Gavin D. Perkins, et al. "Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial." Jama 316 (2016): 509-518.
  8. Google Scholar, Crossref, Indexed at

  9. Nash, Kevin, Abdul Hafeez and Susan Hou. "Hospital-acquired renal insufficiency." Am J Kidney Dis 39 (2002): 930-936.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 784

Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward